UTAH MEDICAL PRODUCTS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $16.74 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-27
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $16.74, a 15.33% decline from fiscal 2024.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $19.77, a 21.20% decline from fiscal 2023.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $25.09, a 0.99% decline from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $25.34.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2025-12-31 | $16.74 10-K · filed 2026-03-27 |
| 2024-12-31 | $19.77 10-K · filed 2026-03-27 |
| 2023-12-31 | $25.09 10-K · filed 2026-03-27 |
| 2022-12-31 | $25.34 10-K · filed 2025-03-26 |
| 2020-12-31 | $16.17 10-K/A · filed 2023-03-28 |
| 2018-12-31 | $15.77 10-K · filed 2021-03-26 |
| 2016-12-31 | $12.15 10-K · filed 2019-03-14 |
| 2014-12-31 | $9.64 10-K · filed 2017-03-08 |
| 2012-12-31 | $3.92 10-K · filed 2015-03-12 |
| 2011-12-31 | $3.09 10-K · filed 2014-03-12 |
| 2010-12-31 | $3.71 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |